MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves (Q35946697)

11 August 2017

1 reference

MDMA

0 references

title

MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves (English)

1 reference

11 August 2017

Parrott AC

1

1 reference

11 August 2017

1 January 2004

1 reference

11 August 2017

1 reference

11 August 2017

50

1 reference

11 August 2017

4

1 reference

11 August 2017

329-335

1 reference

Drug use and life style among college undergraduates: a 30-year longitudinal study

11 August 2017

1 reference

Potential human neurotoxicity of MDMA ('Ecstasy'): subjective self-reports, evidence from an Italian drug addiction centre and clinical case studies

21 January 2018

1 reference

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

The use of drugs within the techno party scene in European metropolitan cities

21 January 2018

1 reference

Patterns of recreational drug use at dance events in Edinburgh, Scotland

21 January 2018

1 reference

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

21 January 2018

1 reference

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

21 January 2018

1 reference

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

21 January 2018

1 reference

Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.

21 January 2018

1 reference

A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation

21 January 2018

1 reference

Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats.

21 January 2018

1 reference

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

21 January 2018

1 reference

Methamphetamine toxicity in mice is potentiated by exposure to loud music.

21 January 2018

1 reference

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

21 January 2018

1 reference

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

21 January 2018

1 reference

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

21 January 2018

1 reference

Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.

21 January 2018

1 reference

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

21 January 2018

1 reference

Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users

21 January 2018

1 reference

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

21 January 2018

1 reference

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

21 January 2018

1 reference

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users

21 January 2018

1 reference

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

21 January 2018

1 reference

Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.

21 January 2018

1 reference

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects

21 January 2018

1 reference

'Weddings, parties, anythingellipsis', a qualitative analysis of ecstasy use in Perth, Western Australia

21 January 2018

1 reference

Understanding reasons for drug use amongst young people: a functional perspective

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000080961

1 reference

11 August 2017

1 reference

PubMed ID

15539865